huMannity Medtec

Home
United States
Valencia, CA
huMannity Medtec

We pioneer life-enhancing medical technologies for undermet healthcare needs.

01/21/2026

What does it take to turn invention into impact when the gap between academic discovery and patient care is often widened by the very metrics meant to bridge it?

Join huMannity Medtec CEO Dr. Bob Greenberg this Thursday at as he dives into the evolving role of non-profits and academia.

Thursday, Jan 22nd | 3:30 PM

01/09/2026

huMannity is headed to the J.P. Morgan Healthcare Conference in San Francisco next week (Jan 12–15, 2026).

Our mission: to bring medical innovation to life by nurturing neurotechnology from promise to product—connecting teams and accelerating progress from ideation to clinical use.

Meet us at JPM and learn how we help innovations earn trust, gain traction, and ultimately reach patients.

01/07/2026

We don’t ask researchers to quit their jobs or lead startups.

If you’re advancing a MedTech concept in neurostimulation or bioelectronic medicine, you can stay focused on your science, while we take the lead on development.

Our in-house team of engineers, scientists, and regulatory experts will guide your idea from concept to clinical readiness.

It’s a model built for researchers who want to see their innovations make an impact without taking on the burdens of commercialization.

Learn more about our unique partnership model: https://www.humannitymedtec.org/pre-development-partners

12/04/2025

When developing next-generation implantable devices, this first question is critical: What exactly are we stimulating?

As John Rivera, our VP of Product Development, explains:

“Not all nerves are the same, and not all conditions can be treated the same way. I’ve heard the phrase ‘stim is stim,’ but that’s incorrect. You have to understand the neuroanatomy and neurophysiology of your target—what it’s composed of and how it behaves.”

Each neural circuit functions differently. A therapy approach that works for chronic pain may not work for movement disorders, and vice versa.

That’s why our process begins with deep research into neural pathways, ensuring that every therapy we develop is tailored to its specific biological target.

11/21/2025

"In med tech innovation, closed-loop systems are one of the hottest concepts shaping the future of care.

Devices with closed-loop systems use biofeedback sensing and real-time data to automatically fine-tune therapy, so they can respond to changes in activity, posture, or symptoms, without any manual input from the patient.

As John Rivera, our VP of Product Development, explains:

“Instead of patients having to change their amplitude or stimulation settings… the system should do it for them.”

By removing the burden of constant device adjustments, closed-loop systems give patients more freedom to live their lives—while ensuring their therapy is always optimized.

At huMannity, we’re working toward smarter, more adaptive solutions that put the patient experience at the center of innovation."

11/13/2025

Lower burden is better care.

When devices reduce manual adjustments, clinic visits, and guesswork, people live their lives with fewer interruptions and less stress.

What this looks like:
Auto-adjustment: sensing and responding in real time for steadier patient relief.
Remote support: secure updates and virtual check-ins that save patient trips.
Usability: clear interfaces and training that reduce patient errors.

We advocate for features that sense, adapt, and support remote care so relief is steadier and days are simpler.

See how we design with burden in mind @ www.humannitymedtec.org/our-work

11/06/2025

Today we honor our founder, Alfred E. Mann on his birthday - an inventor, entrepreneur, and philanthropist whose work in MedTech changed millions of lives for the better.

Al’s vision guides huMannity MedTec today. We continue his focus on practical innovation, patient impact, and access, building on a 40-year legacy that began at the Alfred Mann Foundation.

10/28/2025

See you at Neurotech Leaders Forum, Nov 5–6 (South San Francisco).

huMannity MedTec’s Bob Greenberg, M.D., Ph.D. (Chairman & CEO) will speak on “Navigating the Valley of Death: Building a Sustainable Neuromodulation Business”.

The session runs Day 1, 9:15–10:00 a.m. PT.

This two-day forum brings neurotech executives, entrepreneurs, and investors together for practical sessions on funding, commercialization, BCIs, neuromodulation, and more.

To register and learn more, visit: https://www.neurotechreports.com/pages/leadersforum.html

10/20/2025

When we design a neuromodulation device to "talk" to the body, we’re asking some simple questions:

1) Where are we talking?
Selectivity matters. Lead configuration, electrode design, and current steering help us reach the right nerves—and avoid the wrong ones—for stronger efficacy and fewer side effects.

2) How are we talking?
As John Rivera, our Head of R&D, puts it, dosing is its own language: "Spatially, you’re looking at selectivity—how do you apply stimulation precisely around a nerve...Then there’s the temporal aspect—how do you dose it? Is it a continuous pulse, some kind of burst pattern, a complex waveform, or a combination of these? And how often should it be applied?”

If you’re building implantables, learning the nerve’s “dialect” is where personalization starts.

Learn more about our work: https://www.humannitymedtec.org/our-work

09/26/2025

On September 29th, Dr. Brian Mech, VP of Strategy at huMannity, will deliver a seminar at the University of Minnesota as part of their CNE Seminar Series (Center for Neuroengineering).

With over 25 years of experience in active implantable medical devices—and as an inventor on more than 50 U.S. patents—Brian will share insights on huMannity’s unique approach to accelerating breakthrough medical technologies. He’ll highlight how huMannity’s model addresses the ‘valley of death’ dilemma that stifles so many promising medical device technologies before they even get started.

Attendees will learn about our organization’s history, lessons learned, what we get excited about, and challenges and opportunities ahead.

We look forward to engaging with students, researchers, and innovators as we continue to advance huMannity’s mission: pioneering life-enhancing medical technologies for undermet healthcare needs.

09/15/2025

We don’t ask researchers to quit their jobs or lead startups.

If you’re advancing a med tech concept in neurostimulation or bioelectronic medicine, you can stay focused on your science, while we take the lead on development.

Our in-house team of engineers, scientists, and regulatory experts will guide your idea from concept to clinical readiness.

It’s a model built for researchers who want to see their innovations make an impact without taking on the burdens of commercialization.

Learn more about our unique partnership model: https://www.humannitymedtec.org/pre-development-partners

09/11/2025

Our summer interns recently presented their final projects to the huMannity team!

Their work spanned a variety of engineering disciplines and highlighted the skills they’ve been developing throughout the program.

This was a chance for interns to demonstrate their growth, share creative solutions, and show how they’ve contributed to huMannity’s mission of advancing life-enhancing technologies.

Thank you to all our interns for a fantastic summer!

Address

25134 Rye Canyon Loop, Ste 200
Valencia, CA
91355

Website

https://www.humannitymedtec.org/

Alerts

Be the first to know and let us send you an email when huMannity Medtec posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to huMannity Medtec:

Shortcuts

Featured

Alpha Recovery Center
7316 West Avenue D-8, Lancaster

Want your practice to be the top-listed Clinic in Valencia?